Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Akihiko Kageyama"'
Autor:
Yu Yagi, Yusuke Kanemasa, Yuki Sasaki, An Ohigashi, Yuka Morita, Taichi Tamura, Shohei Nakamura, Akihiko Kageyama, Yasushi Omuro, Tatsu Shimoyama
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background Synchronous multiple primary malignant tumors (sMPMTs) are sometimes diagnosed in patients with malignant lymphoma. We herein investigated the prognostic impact of sMPMT in lymphoma patients and the optimal treatment strategy. Met
Externí odkaz:
https://doaj.org/article/6923958f8d2a49c0a3bda467c6d223dd
Autor:
Ryo Negishi, Hitomi Yamakawa, Takeru Kobayashi, Mayuko Horikawa, Tatsu Shimoyama, Fumiaki Koizumi, Takeshi Sawada, Keisuke Oboki, Yasushi Omuro, Chikako Funasaka, Akihiko Kageyama, Yusuke Kanemasa, Tsuyoshi Tanaka, Tadashi Matsunaga, Tomoko Yoshino
Publikováno v:
Communications Biology, Vol 5, Iss 1, Pp 1-12 (2022)
Ryo Negishi et al. utilize a size-dependent recovery method with gel-based cell manipulation to isolate single circulating tumor cells (CTCs) for transcriptomic analysis. They demonstrate the utility of this approach by analyzing the transcriptomic p
Externí odkaz:
https://doaj.org/article/a86e30aadf1544eabe472e2a9f2ede17
Autor:
Mao Uematsu, Yusuke Kanemasa, Shohei Nakamura, Chikako Funasaka, Akihiko Kageyama, Tatsu Shimoyama, Yasushi Omuro
Publikováno v:
Case Reports in Oncology, Vol 12, Iss 3, Pp 928-934 (2019)
Choriocarcinoma is a highly aggressive germ cell tumor and can metastasize to the brain. Although brain metastasis has a poor prognosis, the optimal treatment strategy remains unclear due to its low incidence. A 33-year-old man presenting with multip
Externí odkaz:
https://doaj.org/article/86f8cb3e5b6743588f4195fdb61abfac
Autor:
Yu, Yagi, Yusuke, Kanemasa, Yuki, Sasaki, Yudai, Hayashi, Mano, Mino, Chika, Kato, Satoshi, Sakai, An, Ohigashi, Yasuhiro, Kanbara, Yuka, Morita, Taichi, Tamura, Yuya, Atsuta, Ryosuke, Konuma, Shohei, Nakamura, Atsushi, Wada, Toshihiro, Okuya, Akihiko, Kageyama, Daisuke, Murakami, Shiori, Nakashima, Yusuke, Uchibori, Daishi, Onai, Atsushi, Hamamura, Akihiko, Nishijima, Yasushi, Omuro, Naoki, Shingai, Takuya, Shimizuguchi, Takashi, Toya, Hiroaki, Shimizu, Yuho, Najima, Takeshi, Kobayashi, Kyoko, Haraguchi, Kazuteru, Ohashi, Noriko, Doki, Yoshiki, Okuyama, Tatsu, Shimoyama
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 63(10)
Chimeric antigen receptor (CAR) T-cell therapy has revolutionized the approach to patients with relapsed or refractory diffuse large B-cell lymphoma (r/r DLBCL). This study retrospectively analyzed patients treated with commercially available tisagen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f5315a8e70ea9f1dbec3ded2572a84d0
https://pubmed.ncbi.nlm.nih.gov/36351641
https://pubmed.ncbi.nlm.nih.gov/36351641
Autor:
Tatsu Shimoyama, Shohei Nakamura, Mao Uematsu, Chikako Funasaka, Yasushi Omuro, Yusuke Kanemasa, Akihiko Kageyama
Publikováno v:
Case Reports in Oncology, Vol 12, Iss 3, Pp 928-934 (2019)
Case Reports in Oncology
Case Reports in Oncology
Choriocarcinoma is a highly aggressive germ cell tumor and can metastasize to the brain. Although brain metastasis has a poor prognosis, the optimal treatment strategy remains unclear due to its low incidence. A 33-year-old man presenting with multip
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c25daf1696c17ae2b1b51b785e81a39b
https://doi.org/10.1159/000504933
https://doi.org/10.1159/000504933
Autor:
Yuki Sasaki, Yusuke Kanemasa, Yasushi Omuro, Shohei Nakamura, Yuka Morita, Yu Yagi, An Ohigashi, Taichi Tamura, Tatsu Shimoyama, Akihiko Kageyama
Publikováno v:
Medicine. 101:e29028
Maintaining relative dose intensity (RDI) of rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) improves the prognosis of patients with diffuse large B-cell lymphoma (DLBCL). Pegfilgrastim was approved in Japan in November
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e209a9e6ed0a1e77ccf587b2dca88ed8
https://doi.org/10.1097/md.0000000000029028
https://doi.org/10.1097/md.0000000000029028
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 47(8)
Standard regimens for extrapulmonary neuroendocrine carcinomas(EPNEC)are not established. Treatment used for small cell lung cancer is also used for EPNECs. Amrubicin(AMR) monotherapy is used as salvage therapy for small cell lung cancer, but its eff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::504fd1a526240d92f96d0935f7110f90
https://pubmed.ncbi.nlm.nih.gov/32829355
https://pubmed.ncbi.nlm.nih.gov/32829355
Autor:
Chikako Funasaka, Yasushi Omuro, Shohei Nakamura, Yusuke Kanemasa, Akihiko Kageyama, Toshihiro Okuya, Yuki Sasaki, Tatsu Shimoyama, Akihito Nagata
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::10132ff5336ef434d6dd0d3e68512f23
https://doi.org/10.1002/hon.2732/v2/response1
https://doi.org/10.1002/hon.2732/v2/response1
Autor:
Yu Yagi, Tatsu Shimoyama, Yuka Morita, An Ohigashi, Masaya Watanabe, Taichi Tamura, Shohei Nakamura, Yasushi Omuro, Akihiko Kageyama, Yusuke Kanemasa
Publikováno v:
Annals of Oncology. 32:S360
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4359dc35af82ead17c59c5884c02f012
https://doi.org/10.1016/j.annonc.2021.05.792
https://doi.org/10.1016/j.annonc.2021.05.792
Autor:
Yu Yagi, Taichi Tamura, An Ohigashi, Tatsu Shimoyama, Shohei Nakamura, Yusuke Kanemasa, Yuka Morita, Akihiko Kageyama, Shinichiro Makino, Yasushi Omuro
Publikováno v:
Annals of Oncology
Background: The COVID-19 pandemic has had various effects on clinical practice. Anticancer chemotherapy is no exception. This time, we investigated the trends of chemotherapy in our hospital and department under the COVID-19 pandemic, and report the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba86a593a5b8fd6eb783f86464b31904
http://europepmc.org/articles/PMC8311563
http://europepmc.org/articles/PMC8311563